Skip to content

H.R. 8018 · 119th Congress (2025–2027)

ISLET Act

This bill removes pancreatic islets that are donated from human cadavers from regulation as a drug or biological product by the Food and Drug Administration (FDA). (Islets are groups of cells, including those that make insulin, in the pancreas, and islet transplantation is an experimental treatment for certain conditions, such as type 1 diabetes.)

Current FDA guidance treats pancreatic islets as a biological product, which makes them subject to the biological license application process and related standards for manufacturing practices, safety, identity, purity, and potency.

The bill, instead, treats human cadaveric islets as organs, which makes them subject to the regulatory framework that governs the allocation, safety, and efficacy of organ donation and transplantation. That framework, developed by the Health Resources and Services Administration, is carried out by contract through the Organ Procurement and Transplantation Network. (The network is a public-private partnership that links the professionals involved in the U.S. donation and transplantation system.)

Specifically, the bill defines human cadaveric islets as organs and excludes them from definitions related to the regulation of drugs and biological products.

Show official title

To regulate human cadaveric islets for transplantation as organs.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 8018’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Ralph Norman (R-SC-5)
Cosponsors
6 cosponsors

1 original · 5 later

6 R

  1. Rep. Don Bacon (R-NE-2)· Original · Mar 19, 2026
  2. Rep. Tracey Mann (R-KS-1)· Later · Mar 24, 2026
  3. Rep. Brandon Gill (R-TX-26)· Later · Apr 21, 2026
  4. Rep. Nick LaLota (R-NY-1)· Later · May 11, 2026
  5. Rep. Andrew R. Garbarino (R-NY-2)· Later · Jun 11, 2026
  6. Rep. Robert P. Bresnahan, Jr. (R-PA-8)· Later · Sep 1, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Mar 19, 2026

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. ISLET Act

    Display title, Short title · Introduced in House

  2. Increase Support for Life-saving Endocrine Transplantation Act

    Short title · Introduced in House

  3. To regulate human cadaveric islets for transplantation as organs.

    Official title · Introduced in House